美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

SpyGlass Pharma Inc

26.28

+10.2864.22%

成交量：92.02萬

成交額：2,370.16萬

市值：8.38億

市盈率：- -

高：32.44

開：24.00

低：20.16

收：16.00

52周最高：32.44

52周最低：20.16

股本：3,191.12萬

流通股本：940.00萬

量比：- -

換手率：9.79%

股息：- -

股息率：- -

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

SpyGlass Pharma Inc

交易所：

NASDAQ

成立時間：

2019

員工人數：

32

公司地址：

27061 Aliso Creek Road,Suite 100,Aliso Viejo,California,United States

官網：

http://www.spyglasspharma.com

郵編：

92656

電話：

傳真：

- -

簡介：

SpyGlass Pharma, Inc.根據特拉華州法律於2019年1月7日註冊成立。該公司是一家處於後期階段的生物製藥公司，正在啟動其先導產品的3期臨床試驗，這是一種IOL掛載、控釋、藥物遞送系統，旨在通過藥物比馬前列素的遞送來治療青光眼。其使命是通過開發持久的藥物遞送解決方案來顯著改善患有慢性眼病的患者的生活，這些解決方案可以讓患者和外科醫生對長期疾病控制和視力保護充滿信心。

董事

名稱

職位

Patrick Mooney

Chief Executive Officer and Director

Ali Behbahani

Independent Director

Bilal Khan

Independent Director

Elizabeth O Farrell

Independent Director

Geoff Pardo

Independent Director

Habib J. Dable

Independent Director

Kirk Nielsen

Independent Director

Malik Y. Kahook

Chief Medical Officer and Director and Executive Chair of the Board and President

Michael Dybbs

Independent Director

Zach Scheiner

Independent Director

股東

名稱

職位

Patrick Mooney

Chief Executive Officer and Director

James Dennewill

Chief Operating Officer

Jean Frederic Viret

Chief Financial Officer

Chetan Pujara

Chief Research and Development Officer

Malik Y. Kahook

Chief Medical Officer and Director and Executive Chair of the Board and President

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hant/stock/SGP/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SGP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGP\",,,,,undefined,":{"symbol":"SGP","market":"US","secType":"STK","nameCN":"SpyGlass Pharma Inc","latestPrice":26.275,"timestamp":1770410130154,"preClose":16,"halted":0,"volume":920248,"delay":0,"changeRate":0.6421874999999999,"floatShares":9400000,"shares":31911200,"eps":0,"marketStatus":"待開盤","change":10.275,"latestTime":"02-06 15:35:30 EST","open":24,"high":32.44,"low":20.16,"amount":23701551.352024,"amplitude":0.7675,"askPrice":27.35,"askSize":100,"bidPrice":25.5,"bidSize":119,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1770411600000},"marketStatusCode":16,"adr":0,"listingDate":1770354000000,"exchange":"NASDAQ","adjPreClose":16,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGP\",,,,,undefined,":{"symbol":"SGP","floatShares":9400000,"roa":"--","roe":"--","lyrEps":0,"shares":31911200,"dividePrice":0,"high":32.44,"amplitude":0.7675,"preClose":16,"low":20.16,"week52Low":20.16,"pbRate":"--","week52High":32.44,"institutionHeld":0,"latestPrice":26.275,"committee":0.086758,"eps":0,"divideRate":0,"volume":920248,"delay":0,"ttmEps":0,"open":24,"prevYearClose":16,"fiveDayClose":16,"twentyDayClose":16,"sixtyDayClose":16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SGP\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SGP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SGP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":618742691,"yearFounded":2019,"employeeNum":32,"address":"27061 Aliso Creek Road,Suite 100,Aliso Viejo,California,United States","zipCode":"92656","officePhone":"(949) 284-6904"},"stockCompanyDetail":{"websiteUrl":"http://www.spyglasspharma.com","compareEarnings":[{"period":"1week","weight":-0.0237},{"period":"1month","weight":-0.0205},{"period":"3month","weight":0.0099},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1215},{"period":"ytd","weight":-0.0063}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"SpyGlass Pharma, Inc.根據特拉華州法律於2019年1月7日註冊成立。該公司是一家處於後期階段的生物製藥公司，正在啟動其先導產品的3期臨床試驗，這是一種IOL掛載、控釋、藥物遞送系統，旨在通過藥物比馬前列素的遞送來治療青光眼。其使命是通過開發持久的藥物遞送解決方案來顯著改善患有慢性眼病的患者的生活，這些解決方案可以讓患者和外科醫生對長期疾病控制和視力保護充滿信心。","exchange":"NASDAQ","name":"SpyGlass Pharma Inc","nameEN":"SpyGlass Pharma Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SGP\",market:\"US\",,,undefined,":{"directors":[{"name":"Patrick Mooney","position":"Chief Executive Officer and Director"},{"name":"Ali Behbahani","position":"Independent Director"},{"name":"Bilal Khan","position":"Independent Director"},{"name":"Elizabeth O Farrell","position":"Independent Director"},{"name":"Geoff Pardo","position":"Independent Director"},{"name":"Habib J. Dable","position":"Independent Director"},{"name":"Kirk Nielsen","position":"Independent Director"},{"name":"Malik Y. Kahook","position":"Chief Medical Officer and Director and Executive Chair of the Board and President"},{"name":"Michael Dybbs","position":"Independent Director"},{"name":"Zach Scheiner","position":"Independent Director"}],"executives":[{"name":"Patrick Mooney","position":"Chief Executive Officer and Director"},{"name":"James Dennewill","position":"Chief Operating Officer"},{"name":"Jean Frederic Viret","position":"Chief Financial Officer"},{"name":"Chetan Pujara","position":"Chief Research and Development Officer"},{"name":"Malik Y. Kahook","position":"Chief Medical Officer and Director and Executive Chair of the Board and President"}]}}}